Visufarma
Netherlands - AmsterdamBiotechnology
Focus: Visufarma is a Netherlands-based biotechnology company specializing in ocular health therapies, founded in 2016 with a focused pipeline in ophthalmology. The company operates as a pre-revenue or early-stage biotech with limited disclosed financial metrics.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Open Jobs
3+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Should You Work at Visufarma?
AI assessmentVisufarma is a speculative early-stage play in ophthalmology with a broad but underdeveloped pipeline; suitable only for risk-tolerant candidates seeking early-stage exposure with European biotech credentials.
Why Work Here
- Emerging player in high-growth ophthalmology market with diverse pipeline covering dry eye disease, glaucoma, and age-related macular degeneration
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
11 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
VisuXL®
Ocular DiscomfortClinical Trials (1)
NCT03844737Evaluation of the VisuXL® Performance on Ocular Surface Discomfort
N/AHelp build intelligence for Visufarma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.